ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
Dow Jones
43,487.83
0.78%
Brent Oil
80.005
0.00%
Bitcoin
103,512.05
-0.59%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Seres Therapeutics Inc (MCRB)

  7. Seres Therapeutics Inc (MCRB) News

MCRB

Seres Therapeutics (MCRB)

Seres Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MCRB
DateTimeSourceHeadlineSymbolCompany
01/16/20257:00AMGlobeNewswire Inc.Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST SaleNASDAQ:MCRBSeres Therapeutics Inc
01/13/20258:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
01/10/20257:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
01/09/20257:00AMGlobeNewswire Inc.Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate UpdatesNASDAQ:MCRBSeres Therapeutics Inc
12/16/20247:00AMGlobeNewswire Inc.Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
12/09/20247:00AMGlobeNewswire Inc.FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)NASDAQ:MCRBSeres Therapeutics Inc
11/22/20247:00AMGlobeNewswire Inc.Seres Therapeutics to Participate in Piper Sandler Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
11/19/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
11/19/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
11/19/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
11/19/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
11/13/202410:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MCRBSeres Therapeutics Inc
11/13/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
11/13/20247:00AMGlobeNewswire Inc.Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
11/06/20247:00AMGlobeNewswire Inc.Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024NASDAQ:MCRBSeres Therapeutics Inc
10/29/20246:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
10/29/20246:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
10/29/20246:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
10/29/20246:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
10/15/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MCRBSeres Therapeutics Inc
10/11/20244:34PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MCRBSeres Therapeutics Inc
10/01/20244:46PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MCRBSeres Therapeutics Inc
10/01/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
09/30/20245:15PMGlobeNewswire Inc.Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.ANASDAQ:MCRBSeres Therapeutics Inc
09/26/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
09/26/20244:01PMGlobeNewswire Inc.Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30NASDAQ:MCRBSeres Therapeutics Inc
09/13/20247:00AMGlobeNewswire Inc.Seres Therapeutics to Participate in Cantor 2024 Global Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
09/12/20248:30AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MCRBSeres Therapeutics Inc
09/12/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
09/12/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MCRB

Your Recent History

BIT
ABC
Abc
BIT
S31830
Societe Generale Effekten
BIT
UB26FQ
UniCredit Bank
BIT
S29326
Societe Generale Effekten
BIT
USSMC
MSCI USA Small Cap ESG L...
BIT
XUTC
Xtrackers MSCI USA Infor...
BIT
1WDC
Westn Digital Dl 10
BIT
EYLD
Wisdomtree Eur Aggregate...
AQSE
VEMT.GB
Vanguard Usd Emerging Ma...
BIT
Q00084
Leonteq Securities
BIT
F39147
Vontobel Financial Produ...
BIT
1BKNG
Booking
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads